TG Therapeutics will host its fourth-quarter and full-year 2025 results call on February 26, with a 2026 outlook that...

Recordati posted preliminary 2025 results that extend its run as one of Europe’s most profitable mid-cap pharmas: net revenue...

Psyence Biomedical secured shareholder approval to elect its slate of directors, appoint MNP LLP as auditor, and grant the...

Cue Biopharma reported new preclinical safety and tolerability data for CUE-401, its lead autoimmune candidate, from non-GLP mouse and...

Oculis has appointed Katie Kazem as Chief Legal Officer to lead legal, compliance, and corporate governance as the company...

Inventiva released preliminary 2025 results showing €99.3 million in cash and €131.6 million in short-term deposits as of December...

Agios has its first broad rare-hematology launch in hand. Following FDA approval in December, Aqvesme (mitapivat 100 mg) is...

Agios Pharmaceuticals will report fourth quarter and full-year 2025 results on February 12, 2026, via webcast. For a rare-hematology...

Beyond Air reported fiscal Q3 revenue of $2.2 million, up 105% year over year and 21% sequentially, turned a...

Medicenna has updated mid‑stage data for its beta‑selective IL‑2 superkine, MDNA11, reporting objective response rates of 36% as monotherapy...